X0508 4 2025-05-28 0001880438 AN2 Therapeutics, Inc. ANTX 0001373603 Leonard Braden Michael 65 E CEDAR - SUITE 2 ZIONSVILLE IN 46077 true false Common Stock 2025-05-28 4 S 0 2000000 1.16 D 3749432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-28 4 S 0 100000 1.16 D 3649432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-30 4 S 0 425000 1.01 D 3224432 I Holding of BML Investment Partners, L.P. Common Stock 2025-05-30 4 S 0 7000 1.0324 D 3217432 I Holding of BML Investment Partners, L.P. BML Capital Management, LLC ("BML Capital") serves as the general partner of BML Investment Partners, L.P., a Delaware limited partnership (the "Fund"), which is the direct owner of the subject shares. Mr. Leonard is the managing member of BML Capital, and exercises investment and voting control over the subject shares. Accordingly, shares owned directly by the Fund may be regarded as being beneficially owned by Mr. Leonard. Notwithstanding, Mr. Leonard disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest therein. The shares were sold in multiple transactions at an average price of $1.0324. Braden Michael Leonard 2025-05-30